KT-621, an Oral, Once Daily STAT6 Degrader: Pharmacokinetics, Pharmacodynamics, and Safety in Healthy Japanese Adults
June 12, 2026
KT-621, an Oral, Once Daily STAT6 Degrader: Pharmacokinetics, Pharmacodynamics, and Safety in Healthy Japanese Adults
Japanese Dermatological Association (JDA) 2026
Sagar Agarwal, Alice A. McDonald, Evelyn Wang, Heather Paleczny, Nello Mainolfi, Jared Gollob, and Michael B. Feldman
Area of Focus
Immunology
Programs
STAT6 (KT-621)
Indications
Healthy Volunteers
Development Stage
Clinical Data
Share
